These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17426086)

  • 61. Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial.
    Pedersen L; Christensen LL; Pedersen SM; Andersen M
    J Endocrinol Invest; 2017 May; 40(5):529-538. PubMed ID: 28000180
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Androgens and cardiac diseases.
    Bianchi V; Mezzani A
    Monaldi Arch Chest Dis; 2013 Dec; 80(4):161-9. PubMed ID: 25087292
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: preliminary results.
    Erfurth EM; Bülow B; Eskilsson J; Hagmar L
    Growth Horm IGF Res; 1999 Apr; 9 Suppl A():21-4. PubMed ID: 10429876
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Androgen therapy in women: an Endocrine Society Clinical Practice guideline.
    Wierman ME; Basson R; Davis SR; Khosla S; Miller KK; Rosner W; Santoro N
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3697-710. PubMed ID: 17018650
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Androgen deficiency in women.
    Miller KK
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2395-401. PubMed ID: 11397829
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The paradox dividing testosterone deficiency symptoms and androgen assays: a closer look at the cellular and molecular mechanisms of androgen action.
    Carruthers M
    J Sex Med; 2008 Apr; 5(4):998-1012. PubMed ID: 18221290
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improvement in scalp hair growth in androgen-deficient women treated with testosterone: a questionnaire study.
    Glaser RL; Dimitrakakis C; Messenger AG
    Br J Dermatol; 2012 Feb; 166(2):274-8. PubMed ID: 21967243
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Management of the androgen-deficient woman.
    Arlt W
    Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S85-9. PubMed ID: 12914732
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Testosterone and cardiovascular disease--the controversy and the facts.
    Morgentaler A; Feibus A; Baum N
    Postgrad Med; 2015 Mar; 127(2):159-65. PubMed ID: 25708023
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Serum testosterone and cardiovascular disease in men].
    Sá EQ; Sá FC; Guedes AD; Verreschi IT
    Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):915-22. PubMed ID: 20126843
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of varying doses of testosterone on atherogenic markers in healthy younger and older men.
    Roberts CK; Chen BH; Pruthi S; Lee ML
    Am J Physiol Regul Integr Comp Physiol; 2014 Jan; 306(2):R118-23. PubMed ID: 24305063
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Plasma steroid concentrations in patients with hypopituitarism and Kallman's syndrome: effects of testosterone replacement therapy.
    Sagel J; Levine JH; Mathur RS; Rosebrock G; Gonzalez J; de Villier C; Nair RM
    Clin Endocrinol (Oxf); 1982 Sep; 17(3):223-31. PubMed ID: 6299618
    [No Abstract]   [Full Text] [Related]  

  • 73. Androgen replacement therapy and cardiovascular function.
    Genazzani AR; Pluchino N
    Climacteric; 2009; 12 Suppl 1():102-7. PubMed ID: 19811252
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Controversies and Advances With Testosterone Therapy: A 40-Year Perspective.
    Morgentaler A
    Urology; 2016 Mar; 89():27-32. PubMed ID: 26683750
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reactive oxygen species: players in the cardiovascular effects of testosterone.
    Tostes RC; Carneiro FS; Carvalho MH; Reckelhoff JF
    Am J Physiol Regul Integr Comp Physiol; 2016 Jan; 310(1):R1-14. PubMed ID: 26538238
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bone marrow hypoplasia responsive to testosterone therapy in a patient with panhypopituitarism: need for adherence to androgen replacement.
    Badawi MA; Salih F; Al-Humaidi AA; El Khalifa MY; Elhadd TA
    Endocr Pract; 2008 Mar; 14(2):229-32. PubMed ID: 18308664
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Androgen deficiency in heart failure.
    Güder G; Allolio B; Angermann CE; Störk S
    Curr Heart Fail Rep; 2011 Jun; 8(2):131-9. PubMed ID: 21387202
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Androgen-Regulated Cardiac Metabolism in Aging Men.
    Barrientos G; Llanos P; Basualto-Alarcón C; Estrada M
    Front Endocrinol (Lausanne); 2020; 11():316. PubMed ID: 32499759
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Clinical interpretation of laboratory parameters in patients with partial age-related androgen deficiency and its complications].
    Pecherskiĭ AV; Semiglazov VF; Mazyrov VI; Karpishchenko AI; Pecherskiĭ VI; Zybina NN; Davydova NI; Kravtsov VIu; Proshin SN; Skorobogatykh MG; Loran OB
    Klin Lab Diagn; 2008 Mar; (3):15-20. PubMed ID: 18453058
    [No Abstract]   [Full Text] [Related]  

  • 80. Testosterone deficiency: a key factor in the increased cardiovascular risk to women following hysterectomy or with natural aging?
    Rako S
    J Womens Health; 1998 Sep; 7(7):825-9. PubMed ID: 9785308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.